MDT Q4 2024 Earnings — Medtronic plc Revenue & Financial Results | Market Cap Arena

MDTMedtronic plc

$116B

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$8.6B+0.5% YoY

Gross Profit

$5.5B64.6% margin

Operating Income

$1.1B12.3% margin

Net Income

$654M7.6% margin

EPS (Diluted)

$0.49

QoQ Revenue Growth

+6.2%

Cash Flow

Operating Cash Flow

$2.8B

Free Cash Flow

$2.4B

Stock-Based Comp.

$90M

Balance Sheet

Total Assets

$90.0B

Total Liabilities

$39.6B

Stockholders' Equity

$50.2B

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8.6B	$8.5B	+0.5%
Gross Profit	$5.5B	$5.6B	-0.4%
Operating Income	$1.1B	$1.6B	-32.7%
Net Income	$654M	$1.2B	-44.5%

Revenue Segments

Cardiac and Vascular Group

$3.1B39%

Neuroscience Group

$2.5B32%

Medical Surgical

$2.1B26%

Diabetes Group

$307M4%

Geographic Segments

UNITED STATES

$4.3B51%

Total Other Countries, Excluding United States and Ireland

$4.2B49%

IRELAND

$28M0%